Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 18 December 2020, 11:00 HKT/SGT
Share:
    

Source: ZENUM Sarl
Five-minute Covid test will reveal if vaccine still works
Identify from a drop of blood whether a person's Covid-19 vaccine is still valid, in 5 Minutes!

Epalinges, Switzerland, Dec 18, 2020 - (ACN Newswire) - Swiss high-tech company ZENUM has developed one of the most advanced technologies in the fight against Covid-19, and it could be ready for distribution as early as next month. The world's first five-minute portable Coronavirus test will also detect how much immunity remains after taking a vaccine.

NANOFLUIDIC RAPID TEST KIT - Identify from a drop of blood whether a person's Covid-19 vaccine is still valid - in 5 Minutes! ZENUM SWITZERLAND 2021

The game-changing ZEKNANO rapid test kit uses a tiny finger-prick blood sample, instead of swabs. It can be taken anywhere, has close to 100% accuracy, and also measures severity of infection. Thanks to nanotechnology, ZEKNANO not only detects Covid-19 within five minutes, but it identifies up to 14 different conditions simultaneously, including flu virus and infectious diseases.

Artificial Intelligence (AI) is at the heart of the revolutionary product. A neural network - a series of algorithms designed to function like a human brain - has been added to increase the test's efficiency, and study any mutation of the virus.

As the device is portable and lightweight, the tests do not have to be administered only in medical settings. This makes it a leading contender to tackle coronavirus and other diseases in the developing world. It also has the potential to help control the pandemic across all countries before another possible surge in the coming months.

ZENUM already produces 15-minute coronavirus rapid test kits for antibodies and antigens, under the brand ZEKMED. The performance evaluation of these kits were conducted by CIRION Biopharma, one of the few CLIA laboratories in Canada. The results are in accordance with three independent evaluations conducted in Russia, Switzerland and France.

The new ZEKNANO five-minute test is expected to be certified for use in January, putting it ahead of several ongoing projects to achieve such rapid results.

Emidio Do Sacramento, founder and CEO of ZENUM, said: "It doesn't matter if it's a 5 or 15 minute rapid test. Our focus is to help practitioners and health institutions, the best we can, to save lives.

"The reality is that the world is in need of products that solve a problem, and not a marketing sales campaign promoting companies or universities, whether that product is from our company or any other.

"Enough is enough. Mass testing, fast and accurate patient triage is the only reliable solution before any vaccine reaches enough people. We need our lives and economy back to 'normal'."

About ZENUM
ZENUM's origins are rooted in a collaborative network of innovators who strive in the development of applications/mediums/security using biometrics, Ai and blockchain technologies and the infinite influences these technologies will have on life.

As a result of our developments in these fields with our project collaborators and likeminded partners, we found ourselves already engaged and working in the field of medical pre-diagnosis using biometric data for example the research into the pre-diagnosis of glaucoma.

ZENUM is located in new facilities at BIOPOLE, the Life Sciences Campus - one of the largest healthcare research campuses in Europe, and has important medical partnerships in Switzerland, Germany and China. Full technical details can be found at https://zekmed.com/zeknano.html

For more information, please contact:
Emidio Do Sacramento, CEO, Zenum
E: es@zenum.swiss, es@zekmed.com, https://zekmed.com

About the CEO:
https://tinyurl.com/Forbes-Sacramento
https://www.linkedin.com/in/emidiosacramento/
https://www.linkedin.com/company/zenum-technologies/



Topic: Press release summary
Source: ZENUM Sarl

Sectors: Healthcare & Pharm, MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
AWM Wraps Up 2025 with Multiple Surf Venue Grand Openings  
Dec 17, 2025 14:16 HKT/SGT
Anson Resources: Update on Cooperation between Anson and POSCO Holdings for DLE Green River Demonstration Plant  
Dec 17, 2025 07:00 HKT/SGT
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards  
Dec 16, 2025 22:00 HKT/SGT
Doubleview Gold Corp Extends Mineralization East of 2024 Conceptual Pit and Identifies Deeper Porphyry Indicators at Hat Project by Drilling 992m of 0.29% CuEq in Hole H101  
Dec 16, 2025 20:29 HKT/SGT
The U.S. Polo Assn. Palm Beaches Marathon Celebrates Record-Breaking Weekend in West Palm Beach, Florida  
Dec 16, 2025 20:00 HKT/SGT
TASPEN Enhances Digital Pension Services with Mobile Biometric Authentication  
Dec 16, 2025 17:00 HKT/SGT
Developers and designers of tomorrow's cities triumph at the 20th PropertyGuru Asia Property Awards Grand Final  
Dec 16, 2025 17:00 HKT/SGT
CTF Life App Becomes Hong Kong's First Life Insurance Mobile Application to Enable Premium Payments via AlipayHK  
Dec 16, 2025 14:51 HKT/SGT
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders  
Dec 16, 2025 14:30 HKT/SGT
CBL International Limited Achieves EcoVadis Silver Medal, Ranking Among Top 15% Globally for Sustainability Performance  
Dec 16, 2025 12:01 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: